Related Articles
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
β‑catenin inhibitors ICG‑001 and pyrvinium sensitize bortezomib‑resistant multiple myeloma cells to bortezomib
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression